AI cannot replace doctors, says IMA Chief

AI cannot replace doctors, says IMA Chief

Dr. R.V. Asokan, the Head of IMA, emphasized that artificial intelligence (AI) cannot supplant doctors but can support them. In a discussion with PTI editors, he highlighted that the medical field historically adopts new technologies but stressed the irreplaceable connection between patients and physicians.

According to Dr. Asokan, “No technology can replace a doctor. In situations where a patient is vulnerable beyond medical treatment, it’s the human touch, empathy, and assurance from a doctor that truly matters.

He acknowledged that advancements like AI, telemedicine, and robotic surgery will enhance healthcare but affirmed that doctors will always remain indispensable. “The art of medicine surpasses its science,” he emphasized.

Regarding violence against doctors, Dr. Asokan called for centralized protection, citing that 23 states have laws but they are ineffective. He also addressed the misconception around criminal liability for medical negligence, emphasizing that civil law, not criminal intent, should govern such cases.

On concerns of pharma influence, he stressed the importance of medical ethics and adherence to regulations, particularly those set by the Medical Council of India.

In response to the National Medical Commission’s new regulations for reasonable working hours, Dr. Asokan advocated for reduced work hours for doctors, citing the significant number of medical graduates produced in India annually.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles

Sign Up for CXO Digital Pulse Newsletters

Sign Up for CXO Digital Pulse Newsletters to Download the Research Report

Sign Up for CXO Digital Pulse Newsletters to Download the Coffee Table Book

Sign Up for CXO Digital Pulse Newsletters to Download the Vision 2023 Research Report

Download 8 Key Insights for Manufacturing for 2023 Report

Sign Up for CISO Handbook 2023

Download India’s Cybersecurity Outlook 2023 Report

Unlock Exclusive Insights: Access the article